BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19455608)

  • 1. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
    Haluska FG; Finver S; Tsujimoto Y; Croce CM
    Nature; 1986 Nov 13-19; 324(6093):158-61. PubMed ID: 3097550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessibility control of V(D)J recombination.
    Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
    Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.
    Marculescu R; Vanura K; Montpellier B; Roulland S; Le T; Navarro JM; Jäger U; McBlane F; Nadel B
    DNA Repair (Amst); 2006 Sep; 5(9-10):1246-58. PubMed ID: 16798110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts in the regulation of an ancient reaction: transposition by RAG1/RAG2.
    Chatterji M; Tsai CL; Schatz DG
    Immunol Rev; 2004 Aug; 200():261-71. PubMed ID: 15242411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
    J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Messier TL; O'Neill JP; Finette BA
    Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.
    Zhang M; Swanson PC
    J Biol Chem; 2008 Mar; 283(11):6717-27. PubMed ID: 18187418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of RAG/DNA complex by HSP70 in V(D)J recombination.
    Son YM; Lee JH; Kim DR
    Biochem Biophys Res Commun; 2008 Jan; 365(1):113-7. PubMed ID: 17980153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V(D)J recombination and the evolution of the adaptive immune system.
    Market E; Papavasiliou FN
    PLoS Biol; 2003 Oct; 1(1):E16. PubMed ID: 14551913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex.
    Raghavan SC; Swanson PC; Wu X; Hsieh CL; Lieber MR
    Nature; 2004 Mar; 428(6978):88-93. PubMed ID: 14999286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining.
    Soulas-Sprauel P; Rivera-Munoz P; Malivert L; Le Guyader G; Abramowski V; Revy P; de Villartay JP
    Oncogene; 2007 Dec; 26(56):7780-91. PubMed ID: 18066091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The taming of a transposon: V(D)J recombination and the immune system.
    Jones JM; Gellert M
    Immunol Rev; 2004 Aug; 200():233-48. PubMed ID: 15242409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.